BlackRock Investment Management, LLC

Holdings History for Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS)

Symbol: CHRS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2016	0%	-0%	$3,249,000	115,414	-646	-0.56%	$28.15	Q4 2016
30 Sep 2016	0%	+0%	$3,108,000	116,060	+1,978	+1.7%	$26.78	Q3 2016
30 Jun 2016	0%	+0%	$1,927,000	114,082	+30,179	+36%	$16.89	Q2 2016
31 Mar 2016	0%	+0%	$1,781,000	83,903	+1,702	+2.1%	$21.23	Q1 2016
31 Dec 2015	0%	+0%	$1,887,000	82,201	+22	+0.03%	$22.96	Q4 2015
30 Sep 2015	0%	-0%	$1,647,000	82,179	-1,067	-1.3%	$20.04	Q3 2015
30 Jun 2015	0%	+0%	$2,406,000	83,246	+83,246	NEW	$28.90	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.